2-bromo-6-chloro-3-iodopyridine | 1211580-38-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-bromo-6-chloro-3-iodopyridine
• CAS: 1211580-38-9
• 化学式: C₅H₂BrClIN
• 分子量: 318.339
• InChiKey: TXAJPIGAKVLANY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-bromo-6-chloro-3-iodopyridine 、 {(2R,3S)-3-[(tert-butyldimethylsilyl)oxy]-2,3-dihydrofuran-2-yl}methanol 在 palladium diacetate 、 silver carbonate 、 三(五氟苯基)膦 、 triethylamine tris(hydrogen fluoride) 作用下， 以 氯仿 、 四氢呋喃 为溶剂， 反应 10.25h， 以59%的产率得到1β-(2-bromo-6-chloropyridin-3-yl)-1,2,3-trideoxy-3-oxo-D-ribofuranose
  参考文献：
  名称：

  Synthesis of 2,6-disubstituted pyridin-3-yl C-2′-deoxyribonucleosides through chemoselective transformations of bromo-chloropyridine C-nucleosides

  摘要：

  通过溴-氯-碘吡啶与 TBS 保护的脱氧核糖糖醛的赫克偶联，制备了 2-溴-6-氯和 6-溴-2-氯吡啶-3-基脱氧核苷。其中一些钯催化的交叉耦合反应在溴的位置上进行化学选择性反应，而亲核取代反应则是非选择性的，得到的产物是混合物。单取代中间体被用于另一种偶联或亲核取代，从而产生了一个小型的 2,6-二取代吡啶 C-脱氧核苷库。标题核苷不具有抗病毒或细胞抑制作用。

  DOI：

  10.1039/c3ob40774h

文献信息

• [EN] 3- (1H-PYRAZOL-4-YL) PYRIDINEALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR<br/>[FR] MODULATEURS ALLOSTÉRIQUES 3-(1H-PYRAZOL-4-YL)PYRIDINE DU RÉCEPTEUR MUSCARINIQUE M4 DE L'ACÉTYLCHOLINE
  申请人：MERCK SHARP & DOHME

  公开号：WO2017107089A1

  公开（公告）日：2017-06-29

  The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

  本发明涉及吡唑-4-基吡啶化合物，其为M4肌碱乙酰胆碱受体的变构调节剂。本发明还涉及所述化合物在潜在的治疗或预防神经系统和精神疾病中的用途，其中M4肌碱乙酰胆碱受体参与其中。本发明还涉及含有这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗M4肌碱乙酰胆碱受体参与的疾病中的用途。
• [EN] ORGANIC COMPOUND, ELECTRONIC COMPONENT. AND ELECTRONIC DEVICE<br/>[FR] COMPOSÉ ORGANIQUE, COMPOSANT ÉLECTRONIQUE ET DISPOSITIF ÉLECTRONIQUE<br/>[ZH] 有机化合物、电子元件和电子装置
  申请人：SHAANXI LIGHTE OPTOELECTRONICS MAT CO LTD

  公开号：WO2022267901A1

  公开（公告）日：2022-12-29

  本申请涉及有机材料领域，提供一种有机化合物、电子元件和电子装置。所述有机化合物具有式1所示的结构，其中，X1～X8各自独立地选自N原子或CH，且至少一个为N原子。本申请的有机化合物能够改善电子元件的性能。
• 3-(1H-PYRAZOL-4-YL) PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
  申请人：MERCK SHARP & DOHME CORP.

  公开号：EP3769763A1

  公开（公告）日：2021-01-27

  The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

  本发明涉及吡唑-4-基吡啶化合物，它们是 M4 肌乙酰胆碱受体的异位调节剂。本发明还涉及本文所述化合物在潜在治疗或预防涉及 M4 肌 肉碱乙酰胆碱受体的神经和精神疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗涉及 M4 蕈样乙酰胆碱受体的此类疾病中的用途。
• 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
  申请人：Merck Sharp & Dohme Corp.

  公开号：US10933056B2

  公开（公告）日：2021-03-02

  The present invention is directed to pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

  本发明涉及吡唑-4-基吡啶化合物，它们是 M4 肌乙酰胆碱受体的异位调节剂。本发明还涉及本文所述化合物在潜在治疗或预防涉及 M4 肌 肉碱乙酰胆碱受体的神经和精神疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在预防或治疗涉及 M4 蕈样乙酰胆碱受体的此类疾病中的用途。
• 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP3393472A1

  公开（公告）日：2018-10-31